Skip to main content

CPS TECHNOLOGIES CORP/DE/

For the period ended Sep 27, 2025. Filed Oct 31, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 27, 2025 · Filed Oct 31, 2025

CPSH$3.83+6.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. FINANCIAL STATEMENTS (Unaudited)

Balance Sheets (Unaudited)

September 27, 2025December 28, 2024
ASSETS
Current assets:
Cash and cash equivalents$3,234,142$3,280,687
Marketable securities, at fair value1,054,0791,031,001
Accounts receivable-trade5,400,0804,858,208
Accounts receivable-other376,652177,068
Inventories, net5,383,6804,331,066
Prepaid expenses and other current assets328,249480,986
Total current assets15,776,88214,159,016
Property and equipment:
Production equipment10,599,47910,382,379
Furniture and office equipment910,310891,921
Leasehold improvements997,830997,830
Total cost12,507,61912,272,130
Accumulated depreciation and amortization(10,737,391)(10,377,756)
Construction in progress216,193108,874
Net property and equipment1,986,4212,003,248
Net intangible assets23,746-
Right-of-use lease asset370,000186,000
Deferred taxes, net2,279,2532,528,682
Total Assets$20,436,30218,876,946
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Note payable, current portion-8,130
Accounts payable3,530,0523,053,712
Accrued expenses1,298,268913,279
Deferred revenue74,257172,429
Lease liability, current portion161,000160,000
Total current liabilities5,063,5774,307,550
Deferred revenue – long term31,27731,277
Long term lease liability209,00026,000
Total liabilities5,303,8544,364,827
Commitments & Contingencies
Stockholders’ equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 14,666,987 and 14,661,487 shares; outstanding 14,529,277 and 14,525,960 shares at September 27, 2025 and December 28, 2024, respectively146,670146,615
Additional paid-in capital40,809,15140,580,387
Accumulated other comprehensive income7,17615,500
Accumulated deficit(25,482,486)(25,890,245)
Less cost of 137,710 and 135,527 common shares repurchased at each September 27, 2025 and December 28, 2024, respectively(348,063)(340,138)
Total stockholders’ equity15,132,44814,512,119
Total liabilities and stockholders’ equity$20,436,302$18,876,946

Statements of Operations and Other Comprehensive Income (Loss) (Unaudited)

Three Months EndedNine Months Ended
September 27, 2025September 28, 2024September 27, 2025September 28, 2024
Product sales$8,803,695$4,247,116$24,388,272$15,190,063
Cost of product sales7,301,1294,770,54820,318,39015,037,177
Gross profit1,502,566(523,432)4,069,882152,886
Selling, general, and administrative expenses1,226,484963,0643,527,2233,214,831
Income (loss) from operations276,082(1,486,496)542,659(3,061,945)
Other income, net45,48370,974114,985241,845
Net income (loss) before income taxes321,565(1,415,522)657,644(2,820,100)
Income tax provision (benefit)113,601(372,683)249,885(679,803)
Net income (loss)$207,964$(1,042,839)$407,759$(2,140,297)
Other comprehensive income
Net unrealized gains (losses) on available for sale securities(2,293)8,7457,91317,446
Reclassification adjustment for gains included in net income--(16,237)-
Total other comprehensive income (loss)(2,293)8,745(8,324)17,446
Comprehensive income (loss)205,671(1,034,094)399,435(2,122,851)
Net income (loss) per basic common share$0.01$(0.07)$0.03$(0.15)
Weighted average number of basic common shares outstanding14,527,12614,525,66414,526,34914,521,365
Net income (loss) per diluted common share$0.01$(0.07)$0.03$(0.15)
Weighted average number of diluted common shares outstanding14,674,38414,525,66414,598,57614,521,365

CPS TECHNOLOGIES CORP.

STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 27, 2025 AND SEPTEMBER 28, 2024

Common Stock
Number of shares issuedPar ValueAdditional paid-in capitalAccumulated other comprehensive incomeAccumulated deficitStock repurchasedTotal stockholders’ equity
Balance at June 28, 202514,661,487$146,615$40,751,927$9,469$(25,690,450)$(340,138)$14,877,423
Share-based compensation expense----49,354------49,354
Employee option exercises5,500557,870----(7,925)--
Other comprehensive loss------(2,293)----(2,293)
Net income--------207,964--207,964
Balance at September 27, 202514,666,987$146,670$40,809,151$7,176$(25,482,486)$(348,063)$15,132,448
Common Stock
Number of shares issuedPar ValueAdditional paid-in capitalAccumulated other comprehensive incomeAccumulated deficitStock repurchasedTotal stockholders’ equity
Balance at December 28, 202414,661,487$146,615$40,580,387$15,500$(25,890,245)$(340,138)$14,512,119
Share-based compensation expense----220,894------220,894
Employee option exercises5,500557,870----(7,925)--
Net unrealized gains on available for sale securities------7,913----7,913
Reclassification adjustment for gains included in net income------(16,237)----(16,237)
Net income--------407,759--407,759
Balance at September 27, 202514,666,987$146,670$40,809,151$7,176$(25,482,486)$(348,063)$15,132,448
Common Stock
Number of shares issuedPar ValueAdditional paid-in capitalAccumulated other comprehensive incomeAccumulated deficitStock repurchasedTotal stockholders’ equity
Balance at June 29, 202414,601,487$146,015$40,386,335$8,701$(23,852,254)$(250,138)$16,438,659
Share-based compensation expense----44,480------44,480
Employee option exercises60,00060089,400----(90,000)--
Other comprehensive income------8,745----8,745
Net loss--------(1,042,839)--(1,042,839)
Balance at September 28, 202414,661,487$146,615$40,520,215$17,446$(24,895,093)$(340,138)$15,449,045
Common Stock
Number of shares issued · Par Value · Additional paid-in capital · Accumulated other comprehensive income · Accumulated deficit · Stock repurchased · Total stockholders’ equity
Balance at December 30, 202314,601,487$146,015$40,180,893$--$(22,754,796)$(250,138)$17,321,974
Share-based compensation expense----249,922------249,922
Employee option exercises60,00060089,400----(90,000)--
Other comprehensive income------17,446----17,446
Net loss--------(2,140,297)--(2,140,297)
Balance at September 28, 202414,661,487$146,615$40,520,215$17,446$(24,895,093)$(340,138)$15,449,045

Statements of Cash Flows (Unaudited)

Nine Months Ended
September 27,September 28,
20252024
Cash flows from operating activities:
Net income (loss)$407,759$(2,140,297)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization458,478369,698
Share-based compensation220,894249,922
Realized gain on sale of marketable securities(11,470)--
Deferred taxes249,429(680,259)
Changes in:
Accounts receivable-trade(541,872)734,606
Accounts receivable-other(199,584)(279,122)
Inventories(1,052,615)148,518
Prepaid expenses and other current assets152,736(145,063)
Accounts payable476,340(38,030)
Accrued expenses384,991(234,379)
Deferred revenue(98,171)(91,343)
Net cash provided by (used in) operating activities446,915(2,105,749)
Cash flows from investing activities-
Purchases of property and equipment(439,492)(895,868)
Acquisition cost of patents and trademarks(25,905)--
Proceeds from sale of marketable securities1,027,000--
Purchase of marketable securities(1,046,933)(1,003,506)
Net cash used in investing activities(485,330)(1,899,374)
Cash flows from financing activities:
Payments on note payable(8,130)(34,784)
Net cash used in financing activities(8,130)(34,784)
Net decrease in cash and cash equivalents(46,545)(4,039,907)
Cash and cash equivalents at beginning of period3,280,6878,813,626
Cash and cash equivalents and restricted cash at end of period$3,234,142$4,773,719
Less: Restricted cash at end of period--84,715
Cash and cash equivalents at end of period3,234,142$4,689,004
Supplemental disclosures of cash flows information:
Cash paid for income taxes--432
Cash paid for interest261,917
Supplemental disclosures of non-cash activity
Disposal of fully depreciated production equipment96,6841,896,631
Share repurchases as a reduction of stock option exercise proceeds7,92590,000

Notes to Financial Statements

(Unaudited)

(1) Nature of Business

CPS Technologies Corporation (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive, defense and other industries. The Company’s primary advanced material solution is metal-matrix composites (“MMC”) which are a combination of metal and ceramic.

CPS also assembles housings and packages for hybrid circuits. These housings and packagesmayinclude components made of metal-matrix composites or theymayinclude components made of more traditional materials such as aluminum.

Using its proprietary MMC technology, the Company also produces light-weight armor, particularly for extreme environments and heavy threat levels.

The Company also engages in research and development, in some cases government funded and in others internally funded, focused on developing new products in response to customer requirements. These products expand our offerings in existing markets and enable penetration into new markets.

(2) Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form10-Q, these notes are condensed and donot contain all disclosures required by generally accepted accounting principles.

The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.

The Company’s balance sheet atDecember 28, 2024has been derived from the audited financial statements at that date, but doesnot include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form10-K for the year endedDecember 28, 2024and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.cpstechnologysolutions.com.

The results of operations for interim periods arenot necessarily indicative of the results to be expected for the full year.

(3) Marketable Securities

Investments consist of U.S. Treasury Bills with maturities up to one year. Since it is not currently managements intention to hold these debt securities until the maturity dates, these have been classified as available-for-sale (“AFS”) and are recorded on the balance sheet at fair value, with changes in fair value recorded as a component of other comprehensive income.

(4) Fair value ofMarketable Securities

ASC 820,Fair Value Measurements (“ASC 820”) states that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The three-tiered fair value hierarchy, which prioritizes which inputs should be used in measuring fair value, is comprised of: (Level I) observable inputs such as quoted prices in active markets; (Level II) inputs other than quoted prices in active markets that are observable either directly or indirectly and (Level III) unobservable inputs for which there is little or no market data. The fair value hierarchy requires the use of observable market data when available in determining fair value. CPS’ marketable securities consist solely of US Government bonds with a maturity of 12 months or less and which fall under Level II of the fair value hierarchy. The value of these bonds as of September 27, 2025 was $1,054,079 and was $1,031,001 as of December 28, 2024.

September 27, 2025December 28, 2024
Cost basis$1,046,903$1,015,501
Unrealized gain7,17615,500
Total fair value$1,054,079$1,031,001

(5) Net Income Per Common and Common Equivalent Share

Basic net income per common share is calculated by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share is calculated by dividing net income by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive. Had there been a profit in Q3 and year to date in 2024, the dilutive effect would have been 41,471 shares and 25,905 shares, respectively.

The following table presents the calculation of both basic and diluted EPS:

Three Months EndedNine Months Ended
September 27, 2025September 28, 2024September 27, 2025September 28, 2024
Basic EPS Computation:
Numerator:
Net income (loss)$207,964$(1,042,839)$407,759$(2,140,297)
Denominator:
Weighted average
Common shares
Outstanding14,527,12614,525,66414,526,34914,521,365
Basic EPS$0.01$(0.07)$0.03$(0.15)
Diluted EPS Computation:
Numerator:
Net income (loss)$207,964$(1,042,839)$407,759$(2,140,297)
Denominator:
Weighted average
Common shares
Outstanding14,527,12614,525,66414,526,34914,521,365
Dilutive effect of stock options147,257--72,227--
Total Shares14,674,38414,525,66414,598,57614,521,365
Diluted EPS$0.01$(0.07)$0.03$(0.15)

(6) Commitments & Contingencies

Commitments

Operating Leases

The Company hasone real estate lease now expiring inFebruary 2028. In August 2025 the Company exercised its option to extend the lease term for two additional years.* CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration.None of these equipment leases have been capitalized as the Company elected an accounting policy for short-term leases, which allows lessees to avoid recognizing right-of-use assets and liabilities for leases with terms of12* months or fewer.

The real estate lease expiring in2028 (the “Norton facility lease”) is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized based on the present value of lease payments over the lease term using the Company’s incremental borrowing rate at commencement date, for the portion expiring in February 2026, and the option exercise date, for the final two years of the lease. The Company’s lease agreements donot contain any material residual value guarantees or material restrictive covenants.

The Norton facility lease comprises approximately 38 thousand square feet. The lease is triple net lease wherein the Company is responsible for payment of all real estate taxes, operating costs and utilities. The Company also has two, two year options to renew the lease inMarch 2028and again inMarch 2030 throughFebruary 2032. The Company is not reasonably certain these extensions will be exercised at this time, and therefore are not included in the lease asset or liability. Annual rental payments range from $165 thousand to $169 thousand through maturity.

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating lease as ofSeptember 27, 2025:

(Dollars in Thousands)September 27, 2025
Maturity of capitalized lease liabilitiesLease payments
202541
2026168
2027169
202828
Total undiscounted operating lease payments$406
Less: Imputed interest(36)
Present value of operating lease liability$370
Balance Sheet Classification
Current lease liability$161
Long-term lease liability209
Total operating lease liability$370
Other Information
Remaining lease term for capitalized operating lease (months)29
Discount rate for capitalized operating leases7.3%

Operating Lease Costs and Cash Flows

Operating lease cost and cash paid was $41 thousand during thethird quarter of2025 and $124 thousand for thenine months ended*September 27, 2025.*These costs are related to its long-term operating lease. All other short-term leases were immaterial.

Finance Leases

The company doesnot have any finance leases.

(7) Share-Based Payments

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The Company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

During the quarter endedSeptember 27, 2025,no stock options were granted to employees under the Company’s2020 Equity Incentive Plan Stock Incentive Plan (the “Plan”) andno stock options were granted to outside directors during the quarter endedSeptember 27, 2025. For the nine months endedSeptember 27,2025 a total of 115,000 stock options and 75,000 stock options were granted to employees and directors, respectively. During the quarter endedSeptember 28, 2024,no stock options were granted to employees under the Company’s2020 Equity Incentive Plan Stock Incentive Plan (the “Plan”) andno stock options were granted to outside directors during the quarter endedSeptember 28, 2024. For the nine months endedSeptember 28,2024 a total of 135,500 stock options and 75,000 stock options were granted to employees and directors, respectively.

During thethree andnine months endedSeptember 27, 2025,there were 5,500 options exercised and corresponding shares issued at a weighted average price of $1.44. During thethree andnine months ended*September 28, 2024,*there were 60,000 options exercised and corresponding shares issued at a weighted average price of $1.50.

During thethree andnine months endedSeptember 27, 2025,the Company repurchased 2,183 shares for employees to facilitate their exercise of stock options. During thethree andnine months ended*September 28, 2024,*the Company repurchased 53,255 shares for employees to facilitate their exercise of stock options.

There were also 1,077,800 options outstanding at a weighted average price of $2.45 with a weighted average remaining term of 7.13 years as of*September 27, 2025,and there were 635,500 options exercisable at a weighted average price of $2.45 with a weighted average remaining term of 6.37 years as ofSeptember 27, 2025.The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As ofSeptember 27, 2025,there were 421,400 shares available for future grants under the 2020 Plan and 138,900 shares outstanding under the 2009 Plan. As ofSeptember 28, 2024,*there were 626,400 shares available for future grants under the 2020 Plan and 248,400 shares outstanding under the 2009 Plan.

As of*September 27, 2025,*there was $509 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 2.68 years.

During thethree andnine months ended*September 27, 2025,*the Company recognized $49,354 and $220,894, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

During thethree andnine months ended*September 28, 2024,*the Company recognized $44,480 and $249,922, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

(8) Inventories

Inventories consist of the following:

September 27,December 28,
20252024
Raw materials$2,422,339$2,625,305
Work in process3,175,8061,880,396
Finished goods328,395343,722
Total inventory5,926,5414,849,423
Reserve for obsolescence(542,860)(518,357)
Inventories, net$5,383,680$4,331,066

(9) Accrued Expenses

Accrued expenses consist of the following:

September 27,December 28,
20252024
Accrued legal and accounting$96,450$138,600
Accrued payroll and related expenses635,051254,737
Accrued product returns465,696429,617
Accrued other101,07190,325
$1,298,268$913,279

(10) Line of Credit

The Company has a $3.0 million revolving line of credit (LOC) with Rockland Trust Company. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of the National Prime Rate as published by the Wall Street Journal (7.25% atSeptember 27, 2025). On*September 27, 2025,*the Company had $0 of borrowings under this LOC and its borrowing base at the time would have permitted an additional $3.0 million to have been borrowed. The line of credit remains in effect and has been extended to August 5, 2026.

(11)Segment Reporting

The Company views its operations and manages its business asone segment. The Company produces and sells advanced material solutions, primarily metal matrix composites, to assemblers of high density electronics and other specialty components and subassemblies. The Company also assembles housings and packages for hybrid circuits, selling to the same customers mentioned above. These customers represent a single market or segment with similar stringent and well-defined requirements. The Company’s customers, in turn, sell the components and subassemblies which incorporate the products into many different end markets, however, these end markets aretwo tothree levels removed from the Company. The Company also sells armor strike faces to armor manufacturers, using the same manufacturing process used in its other product solutions. The Company makes operating decisions and assesses financial performance only for the Company as a whole and doesnot make operating decisions or assess financial performance by the end markets which ultimately use the products. Our chief operating decision maker (CODM) is Brian Mackey, our President and CEO. The Company's CODM regularly reviews financial information presented and does not evaluate the Company's operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.

The following table presents segment information for the Company's single reporting segment:

Three Months EndedNine Months Ended
September 27, 2025September 28, 2024September 27, 2025September 28, 2024
Product Sales$8,803,695$4,247,116$24,388,272$15,190,063
Cost of product sales7,301,1294,770,54820,318,39015,037,177
Gross profit (loss)1,502,566(523,432)4,069,882152,886
Selling, general, and administrative expenses1,226,484963,0643,527,2233,214,831
Income (loss) from operations276,082(1,486,496)542,659(3,061,945)
Other income, net45,48370,974114,985241,845
Income (loss) before income taxes321,565(1,415,522)657,644(2,820,100)
Income tax provision (benefit)113,601(372,683)249,885(679,803)
Net income (loss)$207,964$(1,042,839)$407,759$(2,140,297)

(12) Income Taxes

A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely thannot" that all or a portion of deferred tax assets willnot be realized. Management has determined that a valuation allowance is not needed as it expects that the deferred tax asset will be fully utilized.

For thethree and nine months ended September 27, 2025 the deferred tax asset was decreased $113,601 and $249,429 for the estimated tax provision for Q3 and year to date net income, respectively.

(13) Enactment of the One Big Beautiful Bill Act

On July 4, 2025, the President signed into law the One Big Beautiful Bill Act (Public Law 119-21), which includes significant modifications to the Internal Revenue Code. The legislation permanently extends and modifies key provisions of the Tax Cuts and Jobs Act of 2017 and introduces new deductions and credits applicable to both individuals and businesses.

Key provisions relevant to the Company include:

Restoration of Immediate Expensing for Domestic Research and Experimental (“R&E”***) Expenditures:***Effective for tax years beginning after December 31, 2024, domestic R&E expenditures may be immediately expensed under new Section 174A, reversing the prior capitalization and amortization requirement. This change may materially impact the Company’s deferred tax assets and current tax expense depending on the volume of qualifying expenditures.

During Q3 2025, the Company expensed $899,728 of unamortized Section 174 R&E expenditures.

It is anticipated that the unamortized Section 174 R&E expenditures at Q2 2025 will be expensed as follows (subject to further analyses and discussions):

20252026TotalRationale
Q4 2025187,193-187,193Expense 12.5% of 2022-2024
Q1 2026-187,193187,193Expense 12.5% of 2022-2024
Q2 2026-187,193187,193Expense 12.5% of 2022-2024
Q3 2026-187,193187,193Expense 12.5% of 2022-2024
Q4 2026-187,193187,193Expense 12.5% of 2022-2024
Totals187,193748,772935,965

***Enhancement of Section 179 Expensing:***The maximum Section 179 deduction is increased to $2.5 million, with a phase-out threshold beginning at $4 million. This expansion is expected to accelerate tax deductions for qualifying property and benefit capital investment strategies.

***Permanent Reinstatement of 100% Bonus Depreciation:***For qualified property acquired and placed in service after January 19, 2025, the Company may elect full expensing under Section 168(k), which is expected to accelerate tax deductions and reduce taxable income in applicable periods.

***Modifications to FDII (now FDDEI):***The deduction under Section 250 for foreign-derived intangible income is reduced to 33.34%, and eligibility criteria are narrowed. These changes may impact export-related tax incentives and deferred tax projections tied to U.S.-held IP.

The Company is currently evaluating the impact of these provisions on its financial statements and tax positions. While the changes are not expected to materially affect prior period results, they may influence future effective tax rates, deferred tax balances, and cash tax obligations. The Company will incorporate these changes into its tax planning and provision calculations for fiscal year 2025 and beyond. However, the full effect of these provisions will depend on the Company's future capital expenditures, R&E activities, financing arrangements, and international operations. The Company will incorporate these changes into its tax provision and planning beginning in fiscal year 2025.

(14) Subsequent Events: Equity capital raise

On October 8, 2025 the Company closed an equity raise underwritten by Roth Capital Partners (“Roth”). Roth acquired 3,450,000 shares of the Company’s common stock at a price of $3.00 per share. The net proceeds to the Company were $9,540,025. Had the transaction occurred on the final day of the fiscal quarter, September 27, 2025, the balance sheet would have appeared as follows (changes are italicized):

Balance Sheets (Unaudited)

September 27, 2025December 28, 2024
ASSETS
Current assets:
Cash and cash equivalents$12,774,167$3,280,687
Marketable securities, at fair value1,054,0791,031,001
Accounts receivable-trade5,400,0804,858,208
Accounts receivable-other376,652177,068
Inventories, net5,383,6804,331,066
Prepaid expenses and other current assets328,249480,986
Total current assets25,316,90714,159,016
Property and equipment:
Production equipment10,599,47910,382,379
Furniture and office equipment910,310891,921
Leasehold improvements997,830997,830
Total cost12,507,61912,272,130
Accumulated depreciation and amortization(10,737,391)(10,377,756)
Construction in progress216,193108,874
Net property and equipment1,986,4212,003,248
Net Intangible assets23,746-
Right-of-use lease asset370,000186,000
Deferred taxes, net2,279,2532,528,682
Total Assets$29,976,32718,876,946
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Note payable, current portion-8,130
Accounts payable3,530,0523,053,712
Accrued expenses1,298,268913,279
Deferred revenue74,257172,429
Lease liability, current portion161,000160,000
Total current liabilities5,063,5774,307,550
Deferred revenue – long term31,27731,277
Long term lease liability209,00026,000
Total liabilities5,303,8544,364,827
Commitments & Contingencies
Stockholders’ equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 18,116,987 shares and 14,661,487; outstanding 17,979,277 and 14,525,960 shares at September 27, 2025 and December 28, 2024, respectively181,170146,615
Additional paid-in capital50,314,67640,580,387
Accumulated other comprehensive income7,17615,500
Accumulated deficit(25,482,486)(25,890,245)
Less cost of 137,710 and 135,527 common shares repurchased at each September 27, 2025 and December 28, 2024, respectively(348,063)(340,138)
Total stockholders’ equity24,672,47314,512,119
Total liabilities and stockholders’ equity$29,976,327$18,876,946
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.